EQUITY RESEARCH MEMO

Tailored Clinical Research Solutions

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Tailored Clinical Research Solutions (TCR-Solutions) is a UK-based, full-service Clinical Research Organisation (CRO) specializing in Phase I-IV clinical trials. Founded in 2020 and headquartered in London, the company differentiates itself through a site-focused operational model that emphasizes genuine collaboration with hospital sites to improve trial efficiency and quality. Leveraging deep expertise in hospital research governance, TCR-Solutions provides customized trial management services to biotech, pharmaceutical, academic, and medical device sponsors globally. As a private company with no disclosed funding, TCR-Solutions operates in the competitive CRO market, but its niche focus on hospital partnerships positions it well for growth in the expanding clinical trials outsourcing sector. However, its small size and lack of public financial data introduce uncertainty, warranting a moderate conviction score.

Upcoming Catalysts (preview)

  • Q4 2026Announcement of new hospital partnership agreements in the UK or EU60% success
  • Q2 2027Expansion of service offerings into new therapeutic areas or Phase I unit management45% success
  • Q1 2027Securing a major contract with a top 20 pharmaceutical sponsor30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)